A Phase I Randomized Dose/Formulation Comparison Study of SC-52151

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

Not specified

Conditions

HIV Infections

Interventions

DRUG

Telinavir

Trial Locations (4)

Johns Hopkins Hosp, Baltimore

Univ of Miami School of Medicine, Miami

Ohio State Univ Hosp Clinic, Columbus

Univ of California / San Diego Treatment Ctr, San Diego

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00000806 - A Phase I Randomized Dose/Formulation Comparison Study of SC-52151 | Biotech Hunter | Biotech Hunter